Clinical Trial Update: 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updating the safety and preliminary efficacy of 10-Propargyl-10-Deazaaminopterin in recurrent or refractory lymphoma (non-Hodgkin's and Hodgkin'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• 10-Propargyl-10-Deazaaminopterin

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-08-25